Canada Markets closed

PLx Pharma Inc. (PLXP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.8700-0.1000 (-3.37%)
At close: 04:00PM EDT
2.7300 -0.14 (-4.88%)
After hours: 07:33PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 4.44
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 321.5000
52 Week Low 31.9250
50-Day Moving Average 33.4408
200-Day Moving Average 39.4940

Share Statistics

Avg Vol (3 month) 3245.91k
Avg Vol (10 day) 3288.77k
Shares Outstanding 527.54M
Implied Shares Outstanding 6N/A
Float 820.06M
% Held by Insiders 116.28%
% Held by Institutions 142.80%
Shares Short (Apr 28, 2022) 43M
Short Ratio (Apr 28, 2022) 417.73
Short % of Float (Apr 28, 2022) 411.11%
Short % of Shares Outstanding (Apr 28, 2022) 410.89%
Shares Short (prior month Mar 30, 2022) 43.02M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Apr 19, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:8
Last Split Date 3Apr 19, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)-496.95%

Management Effectiveness

Return on Assets (ttm)-49.38%
Return on Equity (ttm)-141.80%

Income Statement

Revenue (ttm)8.21M
Revenue Per Share (ttm)0.35
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)3.4M
EBITDA -40.67M
Net Income Avi to Common (ttm)-48.65M
Diluted EPS (ttm)-3.1020
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)69.39M
Total Cash Per Share (mrq)2.52
Total Debt (mrq)251k
Total Debt/Equity (mrq)0.48
Current Ratio (mrq)6.18
Book Value Per Share (mrq)1.12

Cash Flow Statement

Operating Cash Flow (ttm)-32.12M
Levered Free Cash Flow (ttm)-17.09M